Shockwave Medical, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Shockwave Medical, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q1 2024.
  • Shockwave Medical, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 107 %, a 223% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 107 +74.1 +223% Mar 31, 2024
Q4 2023 87.6 +54.9 +168% Dec 31, 2023
Q3 2023 60.4 +22.8 +60.6% Sep 30, 2023
Q2 2023 31 -7.59 -19.7% Jun 30, 2023
Q1 2023 33.2 -4.63 -12.2% Mar 31, 2023
Q4 2022 32.7 -3.32 -9.21% Dec 31, 2022
Q3 2022 37.6 +7.59 +25.3% Sep 30, 2022
Q2 2022 38.6 +13.1 +51.6% Jun 30, 2022
Q1 2022 37.9 +16.3 +75.6% Mar 31, 2022
Q4 2021 36.1 +16.3 +82.6% Dec 31, 2021
Q3 2021 30 +10.4 +52.7% Sep 30, 2021
Q2 2021 25.5 +4.21 +19.8% Jun 30, 2021
Q1 2021 21.6 -1.72 -7.39% Mar 31, 2021
Q4 2020 19.7 -2.95 -13% Dec 31, 2020
Q3 2020 19.7 -26.7 -57.6% Sep 30, 2020
Q2 2020 21.2 Jun 30, 2020
Q1 2020 23.3 Mar 31, 2020
Q4 2019 22.7 Dec 31, 2019
Q3 2019 46.4 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.